Participant safety is paramount in clinical trials. Researchers are required to follow strict protocols to minimize risks and monitor participants closely. Any adverse effects must be reported to regulatory bodies immediately. Trials can be halted if safety concerns arise. Additionally, Data Safety Monitoring Boards (DSMBs) oversee the progress of the trial and intervene if necessary to protect participants.
